azepexole has been researched along with ouabain in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gesek, FA; Strandhoy, JW | 1 |
| Thomas, GP | 1 |
| Iaccarino, G; Lembo, G; Rendina, V; Trimarco, B; Volpe, M | 1 |
3 other study(ies) available for azepexole and ouabain
| Article | Year |
|---|---|
Alpha adrenoceptor agonist stimulation of oxygen consumption in rat proximal and distal nephrons.
Topics: Adrenergic alpha-Agonists; Animals; Azepines; Dose-Response Relationship, Drug; Guanabenz; Male; Nephrons; Nystatin; Ouabain; Oxygen Consumption; Rats; Rats, Inbred Strains; Sodium | 1989 |
Studies on the protective effect of azepexole on ouabain-induced cardiac arrhythmias and lethality in guinea-pig.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Azepines; Blood Pressure; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Dioxanes; Female; Guinea Pigs; Heart Rate; Idazoxan; In Vitro Techniques; Male; Ouabain; Reserpine; Yohimbine | 1995 |
Insulin blunts sympathetic vasoconstriction through the alpha 2-adrenergic pathway in humans.
Topics: Adrenergic alpha-Agonists; Adult; Azepines; Blood Pressure; Dose-Response Relationship, Drug; Female; Forearm; Heart Rate; Humans; Infusions, Intra-Arterial; Insulin; Lower Body Negative Pressure; Male; Muscle, Smooth, Vascular; Norepinephrine; Ouabain; Phenylephrine; Prazosin; Receptors, Adrenergic, alpha; Regional Blood Flow; Sodium-Potassium-Exchanging ATPase; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 1994 |